Open | - |
Close | - |
Volume / Avg. | 0 / 495.633K |
Day Range | - - - |
52 Wk Range | 42.210 - 76.980 |
Market Cap | $3.014B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 8.73% |
Days to Cover | 10.47 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immunocore Hldgs (NASDAQ: IMCR) through any online brokerage.
Other companies in Immunocore Hldgs’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX), SpringWorks Therapeutics (NASDAQ:SWTX) and Arrowhead Pharma (NASDAQ:ARWR).
The latest price target for Immunocore Hldgs (NASDAQ: IMCR) was reported by HC Wainwright & Co. on Wednesday, March 6, 2024. The analyst firm set a price target for 90.00 expecting IMCR to rise to within 12 months (a possible 48.78% upside). 31 analyst firms have reported ratings in the last year.
The stock price for Immunocore Hldgs (NASDAQ: IMCR) is $60.49 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Immunocore Hldgs.
Immunocore Hldgs’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Immunocore Hldgs.
Immunocore Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.